Harrison, S. A. Et Al. 2020. RESOLVE-IT PHASE 3 TRIAL OF ELAFIBRANOR IN NASH: FINAL RESULTS OF THE WEEK 72 INTERIM SURROGATE EFFICACY ANALYSIS. AASLD The Liver Meeting , (Virginia, United States Of America), 23.

Harrison, S. A., Ratziu, V., Bedossa, P., Dufour, J., Kruger, F., Schattenberg, J. M., ... Francque, S. M.(2020). RESOLVE-IT PHASE 3 TRIAL OF ELAFIBRANOR IN NASH: FINAL RESULTS OF THE WEEK 72 INTERIM SURROGATE EFFICACY ANALYSIS . AASLD The Liver Meeting (pp.23). Virginia, United States Of America

Harrison, Stephen Et Al. "RESOLVE-IT PHASE 3 TRIAL OF ELAFIBRANOR IN NASH: FINAL RESULTS OF THE WEEK 72 INTERIM SURROGATE EFFICACY ANALYSIS," AASLD The Liver Meeting, Virginia, United States Of America, 2020

Harrison, Stephen A. Et Al. "RESOLVE-IT PHASE 3 TRIAL OF ELAFIBRANOR IN NASH: FINAL RESULTS OF THE WEEK 72 INTERIM SURROGATE EFFICACY ANALYSIS." AASLD The Liver Meeting , Virginia, United States Of America, pp.23, 2020

Harrison, S. A. Et Al. (2020) . "RESOLVE-IT PHASE 3 TRIAL OF ELAFIBRANOR IN NASH: FINAL RESULTS OF THE WEEK 72 INTERIM SURROGATE EFFICACY ANALYSIS." AASLD The Liver Meeting , Virginia, United States Of America, p.23.

@conferencepaper{conferencepaper, author={Stephen A Harrison Et Al. }, title={RESOLVE-IT PHASE 3 TRIAL OF ELAFIBRANOR IN NASH: FINAL RESULTS OF THE WEEK 72 INTERIM SURROGATE EFFICACY ANALYSIS}, congress name={AASLD The Liver Meeting}, city={Virginia}, country={United States Of America}, year={2020}, pages={23} }